Bank of New York Mellon’s Centessa Pharmaceuticals CNTA Stock Holding History

Bank of New York Mellon's CNTA Position: Q2 2026 in Review

Bank of New York Mellon sold out of Centessa Pharmaceuticals (CNTA) in Q2 2026, closing a stake of 8,298 shares — an estimated $330K sold.

Bank of New York Mellon first reported a position in CNTA in Q1 2025 and held it in 4 quarters. The position peaked at $330K in Q1 2026. 0 funds tracked by Wall St. Rank hold CNTA as of Q2 2026.

• Bank of New York Mellon reported no remaining Centessa Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
• Bank of New York Mellon sold 8,298 Centessa Pharmaceuticals shares in Q2 2026, an estimated $330K.
• Bank of New York Mellon first reported a position in Centessa Pharmaceuticals in Q1 2025 and held it in 4 quarters.
• Bank of New York Mellon's Centessa Pharmaceuticals position peaked at $330K in Q1 2026.
• 0 funds tracked by Wall St. Rank held Centessa Pharmaceuticals as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.